The role of costimulatory molecules CD80 and CD86 and IFNγ in the pathogenesis of ulcerative colitis

Digestive Diseases and Sciences

Volumn 49, Issue 11-12, 2004, Pages 1738-1744

  Scarpa, Marco ^a   Behboo, Roubik ^a   Angriman, Imerio ^a   Termini, Barbara ^a   Barollo, Michela ^a   Ruffolo, Cesare ^a   Polese, Lino ^a   D'Incà, Renata ^a   Sturniolo, Giacomo Carlo ^a   D'Amico, Davide Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CD80; CD86; IFN ; Ulcerative colitis

Indexed keywords

B7 ANTIGEN; C REACTIVE PROTEIN; CD86 ANTIGEN; GAMMA INTERFERON; OROSOMUCOID;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; MALE; MOLECULE; PARAMETER; PATHOGENESIS; PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; ULCERATIVE COLITIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTERFERON TYPE II; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; TIME FACTORS; UP-REGULATION;

EID: 13644270381     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-004-9562-7     Document Type: Article

References (29)

1. Fiocchi C: Inflammatory bowel disease: Aetiology and pathogenesis. Gastroenterology 115:182-205, 1998
2. Macpherson A, Khoo UY, Forgacs I, Philpot-Howard J, Bjarson I: Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacterial. Gut 38(3):365-375, 1996
3. Duchmann R, Kaiser I, Hermann H: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 102:448-455, 1995
4. Janeway CJ, Bottomly K: Signals and signs for lymphocyte responses. Cell 76:275-285, 1994
5. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356, 1990
6. Grewal IS, Flavell RA: A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17:410-414, 1996
7. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321-331, 1994
8. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates T cells and prevents induction of anergy in T cell clones. Nature 356:607-609, 1992
9. Nakazawa A, Watanabe M, Kanai T, et al.: Functional expression of co-stimulatory molecule CD86 on epithelial cells in the inflamed colonie mucosa. Gastroenterology 117(3):726-728, 1999
10. Li J, Yang Y, Inoue H, Mori M, Akiyoshi T: The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: Its regulation by interferon and interleukin-10, Cancer Immunol Immunother 43:213-219, 1996
11. Razi-Wolf Z, Hollander GA, Reiser H: Activation of CD4+ T lymphocytes form IL-2 deficient mice co-stimulatory B7 molecules. Proc Natl Acad Sci USA 93:2903-2908, 1996
12. Noguchi M, Hiwatashi N, Liu Z, Toyota T: Enhanced interferon-gamma production and CD86 expression in isolated intestinal mononuclear cells from patients with Crohn's disease. J Gastroenterology 30 (Suppl 8):52-55, 1995
13. Rugtveit J, Bakka A, Brandtzaeg P: Differential distribution of B7.1 and B7.2 co-stimulatory molecules on mucosal macrophage subsets in human IBD. Clin Exp Immunol 110(1):104-113, 1997
14. Rogler G, Hausmann M, Spottl T, Vogl D, Aschenbrenner E, Andus T, Scholmerich J, Gross V: T-cell co - stimulatory molecules are up regulated on intestinal macrophage from inflammatory bowel disease mucosa. Eur J Gastroenterol Hepatol 11:1105-1111, 1999
15. Vuckovic S, Florin FHJ, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DNJ: CD40 and CD86 up regulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 96(10):2946-2956, 2001
16. Polese L, Angriman I, Cecchetto A, Norberto L, Scarpa M, Ruffolo C, Barollo M, Sommariva A, D'Amico DF: The role of CD40 in ulcerative colitis: Histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol 14:237-241, 2002
17. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M: An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87(8):971-976, 1992
18. Seo M, Okada M, Yao T, et al.: Evaluation of disease activity in patients with moderately active ulcerative colitis: Comparison between a new activity index and Truelove and Wilts classification. Am J Gastroenterol 90(10): 1759-1763, 1995
19. Baron JH, Connell AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1:89-92, 1964
20. Florén C-H, Benoni C, Willén R: Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 22:458-462, 1987
21. Stagg AJ, Hart AL, Knight SC, Kamm MA: The dendritic cell: Its role in intestinal inflammation and relationship with gut bacteria. Gut 53:1522-1529, 2003
22. Pepys MB, Hirschfield GM: C-Reactive protein: A critical update. J Clin Invest 111(12):1805-1812, 2003
23. Liskens RK, Van Bodegraven AA, Schoorl M, Tuynman HARE, Bartels P: Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci 46(3):644-648, 2001
24. Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, Ransil B, Wild G, Cohen A, Edwardes MD, Stevens AC: Clinical, biologic, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120:13-20, 2001
25. Mahida YR, Kurlak L, Gallagher A, Hawkey CJ: High circulating levels of IL6 in active Crohn's disease but noit in ulcerative colitis. Gut 32:1531-1534, 1991
26. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegarard NHH: Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 95(2):359-367, 2000
27. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Harutari k, Kuroiwa A, Ina K, Kanayama K, Ando T, Matsuura T, Yamaguchi T, Morise K, Ieda M, Iokowa H, Ishiara A, Sarai S: Elevation of IL6 in inflammatory bowel disease is macrophage and epithelial cell dependent. Dig Dis Sci 40:949-959, 1995
28. Dijkman R, Bilau A: Interferon-gamma: a key master in immune system. Curr Opin Immunol 1:269-274, 1988
29. Farrar MA, Schreiber RD: The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611, 1993